Figure 10
From: Fluoxetine modulates breast cancer metastasis to the brain in a murine model
Tumor size in samples analyzed for glial activation in the vicinity of brain metastases. Tumor size was determined for each image used in the quantitative analysis of microglial and astrocytic activation. The comparison revealed no significant differences between the size of tumors between the control and fluoxetine groups. Iba-1, p = 0.95; CD11b, p = 0.58; IA-IE, p = 0.16; CD68, p = 0.59; CD45, p = 0.74; GFAP, p = 0.86, t-test. n = 20-24.